Hub AI research

Artificial Intelligence is already part of everyday life. Since the ImageNet moment in 2012, when Deep Learning proved its great utility in combination with a lot of computing power and gigantic amounts of data, only about ten years have passed – yet there has been more progress than in half a century before.

Still, many questions remain: Will Deep Learning remain the gold standard of AI development? What are the performance limits of large AI systems? Do we need symbolic systems? What technology will lead to artificial general intelligence? Finally, what actually is intelligence, anyway?

We explore these topics and more in our Artificial Intelligence Research Content Hub.

AI research

Sep 9, 2023Sep 9, 2023

In their quest for AGI safety, researchers are turning to mathematical proof

AI research

Jun 18, 2023Jun 18, 2023

Chatbots allow people with no lab training to create pandemic viruses, study finds

AI research

Apr 2, 2023

The Alpaca Formula: How ChatGPT drives open source AI development

AI research

Apr 25, 2024Apr 25, 2024

Study reveals tension between a LLM's prior knowledge and reference data

AI research

Apr 24, 2024Apr 24, 2024

Short

According to a recent survey conducted by ZoomRx, two-thirds of the 20 largest pharmaceutical companies prohibit their employees from using ChatGPT due to security concerns regarding sensitive internal data. Nevertheless, many life sciences professionals use ChatGPT regularly, even though 83 percent say the technology is "overrated." Despite the potential for increased efficiency and effectiveness through the use of AI in drug development, the majority of pharmaceutical companies are cautious about the technology due to security risks. Most companies see AI primarily as a means to reduce costs, while concerns about data security and privacy remain. But there are exceptions. According to OpenAI, Moderna is using ChatGPT in a pilot project called Dose ID to analyze and visualize large data sets and determine the optimal vaccine dose.

Fierce Pharma